Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine

Br J Haematol. 2000 Jun;109(4):900-1. doi: 10.1046/j.1365-2141.2000.109004900.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia, Hairy Cell / drug therapy*
  • Male
  • Middle Aged
  • Remission Induction / methods
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab